Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 2
2001 2
2002 2
2004 1
2005 1
2007 1
2008 1
2009 4
2010 5
2011 4
2012 2
2013 3
2014 5
2015 6
2016 11
2017 5
2018 12
2019 11
2020 16
2021 13
2022 13
2023 15
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for sarah bladder
Your search for Sarah Blader retrieved no results
Role of FGFR3 in bladder cancer: Treatment landscape and future challenges.
Ascione CM, Napolitano F, Esposito D, Servetto A, Belli S, Santaniello A, Scagliarini S, Crocetto F, Bianco R, Formisano L. Ascione CM, et al. Cancer Treat Rev. 2023 Apr;115:102530. doi: 10.1016/j.ctrv.2023.102530. Epub 2023 Feb 28. Cancer Treat Rev. 2023. PMID: 36898352 Free article. Review.
Bladder cancer is a heterogeneous malignancy and is responsible for approximately 3.2% of new diagnoses of cancer per year (Sung et al., 2021). ...FGFR3 gene rearrangements are typical alterations in bladder cancer (Nelson et al., 2016; Parker et al., 2014). In this …
Bladder cancer is a heterogeneous malignancy and is responsible for approximately 3.2% of new diagnoses of cancer per year (Sung et a …
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials.
Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group. Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group. Eur Urol. 2022 Jan;81(1):50-61. doi: 10.1016/j.eururo.2021.09.028. Epub 2021 Nov 19. Eur Urol. 2022. PMID: 34802798 Free PMC article. Review.
CONCLUSIONS: This systematic review and meta-analysis demonstrates that cisplatin-based adjuvant chemotherapy is a valid option for improving outcomes for muscle-invasive bladder cancer. PATIENT SUMMARY: We looked at the effect of cisplatin-based chemotherapy on outcomes i …
CONCLUSIONS: This systematic review and meta-analysis demonstrates that cisplatin-based adjuvant chemotherapy is a valid option for improvin …
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV; CCGA Consortium. Liu MC, et al. Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30. Ann Oncol. 2020. PMID: 33506766 Free PMC article.
Stage I-III sensitivity was 67.3% (CI: 60.7% to 73.3%) in a pre-specified set of 12 cancer types (anus, bladder, colon/rectum, esophagus, head and neck, liver/bile-duct, lung, lymphoma, ovary, pancreas, plasma cell neoplasm, stomach), which account for 63% of US cancer dea …
Stage I-III sensitivity was 67.3% (CI: 60.7% to 73.3%) in a pre-specified set of 12 cancer types (anus, bladder, colon/rectum, esopha …
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.
Tarantino P, Modi S, Tolaney SM, Cortés J, Hamilton EP, Kim SB, Toi M, Andrè F, Curigliano G. Tarantino P, et al. JAMA Oncol. 2021 Dec 1;7(12):1873-1881. doi: 10.1001/jamaoncol.2021.3595. JAMA Oncol. 2021. PMID: 34647966 Review.
Novel conjugates are now showing activity in trials of other ERBB2-associated tumors, leading to the recent US Food and Drug Administration approval of trastuzumab deruxtecan for ERBB2-positive gastric cancer, as well as beneficial results in colorectal, lung, and bladder …
Novel conjugates are now showing activity in trials of other ERBB2-associated tumors, leading to the recent US Food and Drug Administration …
Sucrose for analgesia in newborn infants undergoing painful procedures.
Stevens B, Yamada J, Ohlsson A, Haliburton S, Shorkey A. Stevens B, et al. Cochrane Database Syst Rev. 2016 Jul 16;7(7):CD001069. doi: 10.1002/14651858.CD001069.pub5. Cochrane Database Syst Rev. 2016. PMID: 27420164 Free PMC article. Review.
The effectiveness of sucrose for reducing pain/stress from other interventions such as arterial puncture, subcutaneous injection, insertion of nasogastric or orogastric tubes, bladder catherization, eye examinations and echocardiography examinations are inconclusive. ...
The effectiveness of sucrose for reducing pain/stress from other interventions such as arterial puncture, subcutaneous injection, insertion …
Managing female sexual dysfunction.
Arthur SS, Dorfman CS, Massa LA, Shelby RA. Arthur SS, et al. Urol Oncol. 2022 Aug;40(8):359-365. doi: 10.1016/j.urolonc.2021.06.006. Epub 2021 Jul 8. Urol Oncol. 2022. PMID: 34247907 Free PMC article. Review.
Bladder leiomyoma treated with transurethral resection of bladder tumor (TURBT): Case report.
AlHalak R, Alkabbani S, Nasseif H, Oghanna N, Janahi F. AlHalak R, et al. Int J Surg Case Rep. 2022 Sep;98:107464. doi: 10.1016/j.ijscr.2022.107464. Epub 2022 Jul 30. Int J Surg Case Rep. 2022. PMID: 36007408 Free PMC article.
MRI and US confirmed the presence of an oval-shaped mass lesion arising from the base of the urinary bladder. Tissue biopsy and immunohistochemistry confirmed the diagnosis of bladder leiomyoma. ...CONCLUSION: This case highlights a rare bladder leiomy …
MRI and US confirmed the presence of an oval-shaped mass lesion arising from the base of the urinary bladder. Tissue biopsy an …
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.
Kamat AM, Apolo AB, Babjuk M, Bivalacqua TJ, Black PC, Buckley R, Campbell MT, Compérat E, Efstathiou JA, Grivas P, Gupta S, Kurtz NJ, Lamm D, Lerner SP, Li R, McConkey DJ, Palou Redorta J, Powles T, Psutka SP, Shore N, Steinberg GD, Sylvester R, Witjes JA, Galsky MD. Kamat AM, et al. J Clin Oncol. 2023 Dec 10;41(35):5437-5447. doi: 10.1200/JCO.23.00307. Epub 2023 Oct 4. J Clin Oncol. 2023. PMID: 37793077 Free PMC article.
RESULTS: The consensus panel developed a set of stage-specific bladder cancer clinical trial design recommendations, which are summarized in the table that accompanies this text. CONCLUSION: These recommendations developed by the SITC-IBCG Bladder Cancer Clinical Tr …
RESULTS: The consensus panel developed a set of stage-specific bladder cancer clinical trial design recommendations, which are summar …
[Melanosis of the bladder-a rare diagnosis].
Hagmann S, Born D, Schmid HP, Rührup J. Hagmann S, et al. Urologie. 2023 Nov;62(11):1200-1203. doi: 10.1007/s00120-023-02127-z. Epub 2023 Jun 27. Urologie. 2023. PMID: 37367951 Free PMC article. German.
Melanosis of the urinary bladder is an extremely rare benign condition in which melanin deposits occur in the urothelial and stromal cells. We report such a case in which melanosis of the urinary bladder was detected in a 55-year-old woman with known m …
Melanosis of the urinary bladder is an extremely rare benign condition in which melanin deposits occur in the urothelial and s …
The Use of Neuromodulation for Symptom Management.
Farrell SM, Green A, Aziz T. Farrell SM, et al. Brain Sci. 2019 Sep 12;9(9):232. doi: 10.3390/brainsci9090232. Brain Sci. 2019. PMID: 31547392 Free PMC article. Review.
Pain and other symptoms of autonomic dysregulation such as hypertension, dyspnoea and bladder instability can lead to intractable suffering. Incorporation of neuromodulation into symptom management, including palliative care treatment protocols, is becoming a viable option …
Pain and other symptoms of autonomic dysregulation such as hypertension, dyspnoea and bladder instability can lead to intractable suf …
123 results